CancerTYPE ID^®

Helping your doctor diagnose your cancer

Cancer may be found at a location in your body that is not the original or “primary” site of the cancer due to cancer cells’ ability to spread from one place to another (cancer that has spread to multiple locations is called a metastatic cancer). Accurately identifying the primary site of your cancer helps your doctor correctly classify it, which is the first step toward personalized treatment.

Cancer type identification significantly impacts your treatment selection

Different types of cancer exhibit unique behaviors and therefore respond differently to specific therapies. A treatment plan tailored to your exact type of cancer can lead to significant improvement in your response.

Conventional diagnostic tools can lack certainty

The diagnostic workup for patients with a hard-to-identify cancer can be cumbersome, lengthy, and expensive, averaging nearly $18,000.¹ Traditional diagnostic tools used for identifying a type of cancer include studying cells and tumors with microscopes, laboratory cell stains, and imaging. These techniques, even when combined, often fall short of identifying where a cancer started and what type it is.

Molecular diagnostics provides important information for cancer type identification

CancerTYPE ID is a new molecular diagnostic test that provides information beyond conventional clinical tools to help identify a cancer type. The activity levels of 92 genes² in a cancer, as measured in the CancerTYPE ID test, contain a rich source of information. This “molecular fingerprint” can provide critical pieces of evidence to help resolve any uncertainties about the primary origin of a cancer, and assist your doctor in selecting the appropriate therapy for you.

CancerTYPE ID increases diagnostic accuracy

bioTheranostics fills an important diagnostic need with the CancerTYPE ID molecular test, a faster, effective, and more objective diagnostic tool. CancerTYPE ID evaluates the molecular signature of the cancer cell to determine where it originated. The CancerTYPE ID test can help your doctor trace the tumor back to its original location, classify the cancer, and initiate a unique therapy plan much more quickly than through conventional methods.

By incorporating CancerTYPE ID into the diagnostic process, your doctor can confirm a classification more quickly, avoid expensive, time consuming, and redundant imaging procedures, and select the therapy appropriately established for your primary cancer.

References:
1. Schapira DV, Jarrett AR. The need to consider survival, outcome, and expense when evaluating and treating patients with unknown primary carcinoma. Arch Inter Med.;155:2050-2054, 1995.
2. Data on file.  Technical Report 021510, bioTheranostics.